Klor-con and Xtampza er drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Klor-con (potassium chloride) and Xtampza er (oxycodone). Common drug interactions include pneumonitis among females and limb injury among males.

The phase IV clinical study analyzes what interactions people have when they take Klor-con and Xtampza er. It is created by eHealthMe based on reports of 12 people who take the same drugs from the FDA, and is updated regularly.

What is Klor-con?

Klor-con has active ingredients of potassium chloride. It is often used in hypokalemia. eHealthMe is studying from 27,547 Klor-con users. Check the latest studies of Klor-con.

What is Xtampza er?

Xtampza er has active ingredients of oxycodone. eHealthMe is studying from 1,502 Xtampza er users. Check the latest studies of Xtampza er.

On Jul, 06, 2026

12 people who take Klor-con and Xtampza er together, and have interactions are studied.

Klor-con and Xtampza er drug interactions.

What are the common drug interactions of Klor-Con and Xtampza Er, by gender? *:

female:

Pneumonitis (inflammation of the walls of the alveoli in the lungs)
Blood sodium decreased
Carbon dioxide decreased
Cellulitis (infection under the skin)
Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)
Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
Clostridium difficile colitis (inflammation of colon by clostridium difficile bacteria infection)
Dehydration (dryness resulting from the removal of water)
Diarrhoea
Dizziness

male:

Limb injury

What are the common drug interactions of Klor-Con and Xtampza Er, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

Pneumonitis (inflammation of the walls of the alveoli in the lungs)
Cytokine release syndrome (immediate complication occurring with the use of anti-t cell antibody infusions)
Clostridium difficile colitis (inflammation of colon by clostridium difficile bacteria infection)
Dehydration (dryness resulting from the removal of water)
Diarrhoea
Dizziness
Fall
Hepatic mass
Hyperkalaemia (damage to or disease of the kidney)
Hypophagia (reduced food intake)

What are the existing conditions these people have? *

Burkitt Lymphoma (cancer of the lymphatic system): 4 people, 33.33%
Multiple Myeloma (cancer of the plasma cells): 2 people, 16.67%
Tooth Abscess (pus formation in tooth): 1 person, 8.33%
Spinal Osteoarthritis (joint cartilage loss in spine): 1 person, 8.33%
Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 1 person, 8.33%
Pancreatic Carcinoma (pancreatic cancer): 1 person, 8.33%
Pain: 1 person, 8.33%
Osteoporosis (bones weak and more likely to break): 1 person, 8.33%
Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 1 person, 8.33%
Metastatic Renal Cell Carcinoma (spreadable kidney cell tumour): 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Klor-con and Xtampza er?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously